McGann, Patrick T.

Hydroxyurea for children with sickle cell anemia in Sub-Saharan Africa

Tshilolo, L., Tomlinson, G., Williams, T. N., Santos, B., Olupot-Olupot, P., Lane, A., Aygun, B., Stuber, S. E., Latham, T. S., McGann, P. T., et al. (2019) · New England Journal of Medicine

Hemoglobinopathies and Related DisordersBlood groups and transfusion

Cited by 376

Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia

McGann, P. T., Niss, O., Dong, M., Marahatta, A., Howard, T. A., Mizuno, T., Lane, A., Kalfa, T. A., Malik, P., Quinn, C. T., et al. (2019) · American Journal of Hematology

Hemoglobinopathies and Related DisordersPharmaceutical studies and practices

Cited by 105

Prevalence of iron deficiency and iron-deficiency anemia in US females aged 12–21 years, 2003–2020

Weyand, A. C., Chaitoff, A., Freed, G. L., Sholzberg, M., Choi, S. W., & McGann, P. T. (2023) · JAMA

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 102

Hydroxyurea in pregnancy: Reframing the conversation

Yasin, F., McGann, P., & Van Doren, L. (2024) · American Journal of Hematology

Pregnancy and Medication ImpactPharmacological Effects and Toxicity Studies

Cited by 6